Phosphorothioate-modified antisense oligonucleotide (PS-ASO) drugs are commonly used to modulate gene expression through RNase H1-mediated cleavage of target RNAs. Upon internalization through endocytic pathways into cells, PS-ASOs must be released from membraned endosomal organelles to act on target RNAs, a limiting step of PS-ASO activity. Here we report that Hsc70 protein mediates productive release of PS-ASOs from endosomes. Hsc70 protein was enriched in endosome fractions shortly after PS-ASO incubation with cells. Reduction of Hsc70 significantly decreased the activities of PS-ASOs in reducing target RNAs. PS-ASO uptake and transport from early endosomes to late endosomes (LEs) were not affected upon Hsc70 reduction; however, endosomal release of PS-ASOs was impaired. Reduction of Hsc70 led to more scattered mannose-6-phosphate receptor (M6PR) localization at LEs in the cytoplasm, in contrast to the perinuclear localization at trans-Golgi network (TGN) in control cells, suggesting that retrograde transport of M6PR from LEs to TGN was affected. Consistently, reduction of Hsc70 increased colocalization of M6PR and PS-ASOs at LEs, and also delayed M6PR antibody transport from LE to TGN. Together, these results suggest that Hsc70 protein is involved in M6PR vesicle escape from LEs and may thus enhance PS-ASO release from LEs.
LimaW, WuH and CrookeST. (2008). The RNase H mechanism. In: Antisense Drug Technology—Principles, Strategies, and Applications, 2nd ed. Crooke ST, ed. (2008). CRC Press, Boca Raton, FL, pp 47–74.
3.
CrookeST, VickersTA, LimaWF and WuH-J. (2008). Mechanisms of antisense drug action, an introduction. In: Antisense Drug Technology—Principles, Strategies, and Applications, 2nd ed. Crooke ST, ed. CRC Press, Boca Raton, FL, pp 3–46.
4.
SwayzeEE and BhatB. (2008). The medicinal chemistry of oligonucleotides. In: Antisense Drug Technology—Principles, Strategies, and Applications, 2nd ed. Crooke ST, ed. CRC Press, Boca Raton, FL, pp 143–182.
5.
CrookeST, WangS, VickersTA, ShenW and LiangXH. (2017). Cellular uptake and trafficking of antisense oligonucleotides. Nat Biotechnol, 35:230–237.
6.
LiangXH, SunH, NicholsJG and CrookeST. (2017). RNase H1-dependent antisense oligonucleotides are robustly active in directing RNA cleavage in both the cytoplasm and the nucleus. Mol Ther, 25:2075–2092.
7.
JulianoRL, CarverK, CaoC and MingX. (2013). Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides. J Drug Target, 21:27–43.
8.
WangS, SunH, TanowitzM, LiangXH and CrookeST. (2016). Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides. Nucleic Acids Res, 44:7314–7330.
9.
LinnaneE, DaveyP, ZhangP, PuriS, EdbrookeM, ChiarparinE, RevenkoAS, MacleodAR, NormanJC and RossSJ. (2019). Differential uptake, kinetics and mechanisms of intracellular trafficking of next-generation antisense oligonucleotides across human cancer cell lines. Nucleic Acids Res, 47:4375–4392.
10.
WangS, SunH, TanowitzM, LiangXH and CrookeST. (2017). Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides. Nucleic Acids Res, 45:5309–5322.
11.
MillerCM, WanWB, SethPP and HarrisEN. (2018). Endosomal escape of antisense oligonucleotides internalized by stabilin receptors is regulated by Rab5C and EEA1 during endosomal maturation. Nucleic Acid Ther, 28:86–96.
12.
KollerE, VincentTM, ChappellA, DeS, ManoharanM and BennettCF. (2011). Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res, 39:4795–4807.
13.
Juliano RL. (2016). The delivery of therapeutic oligonucleotides. Nucleic Acids Res, 44:6518–6548.
14.
Juliano RL. (2018). Intracellular trafficking and endosomal release of oligonucleotides: what we know and what we don't. Nucleic Acid Ther, 28:166–177.
15.
BuntzA, KillianT, SchmidD, SeulH, BrinkmannU, RavnJ, LindholmM, KnoetgenH, HauckeV and MundiglO. (2019). Quantitative fluorescence imaging determines the absolute number of locked nucleic acid oligonucleotides needed for suppression of target gene expression. Nucleic Acids Res, 47:953–969.
16.
LiangXH, SunH, HsuCW, NicholsJG, VickersTA, De HoyosCL and CrookeST. (2020). Golgi-endosome transport mediated by M6PR facilitates release of antisense oligonucleotides from endosomes. Nucleic Acids Res, 48:1372–1391.
17.
JulianoRL and CarverK. (2015). Cellular uptake and intracellular trafficking of oligonucleotides. Adv Drug Deliv Rev, 87:35–45.
18.
LiangXH, SunH, ShenW and CrookeST. (2015). Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages. Nucleic Acids Res, 43:2927–2945.
CrookeST, SethPP, VickersTA and LiangXH. (2020). The interaction of phosphorothioate-containing RNA targeted drugs with proteins is a critical determinant of the therapeutic effects of these agents. J Am Chem Soc, 142:14754–14771.
21.
ZanettiG, PahujaKB, StuderS, ShimS and SchekmanR. (2011). COPII and the regulation of protein sorting in mammals. Nat Cell Biol, 14:20–28.
22.
LiangXH, SunH, NicholsJG, AllenN, WangS, VickersTA, ShenW, HsuCW and CrookeST. (2018). COPII vesicles can affect the activity of antisense oligonucleotides by facilitating the release of oligonucleotides from endocytic pathways. Nucleic Acids Res, 46:10225–10245.
23.
AllanBB, MoyerBD and BalchWE. (2000). Rab1 recruitment of p115 into a cis-SNARE complex: programming budding COPII vesicles for fusion. Science, 289:444–448.
24.
RoweT, DascherC, BannykhS, PlutnerH and BalchWE. (1998). Role of vesicle-associated syntaxin 5 in the assembly of pre-Golgi intermediates. Science, 279:696–700.
25.
Pfeffer SR. (2009). Multiple routes of protein transport from endosomes to the trans Golgi network. FEBS Lett, 583:3811–3816.
26.
BonifacinoJS and RojasR. (2006). Retrograde transport from endosomes to the trans-Golgi network. Nat Rev Mol Cell Biol, 7:568–579.
27.
CoutinhoMF, PrataMJ and AlvesS. (2012). Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction. Mol Genet Metab, 105:542–550.
28.
ReddyJV, BurgueteAS, SrideviK, GanleyIG, NottinghamRM and PfefferSR. (2006). A functional role for the GCC185 golgin in mannose 6-phosphate receptor recycling. Mol Biol Cell, 17:4353–4363.
29.
HayesGL, BrownFC, HaasAK, NottinghamRM, BarrFA and PfefferSR. (2009). Multiple Rab GTPase binding sites in GCC185 suggest a model for vesicle tethering at the trans-Golgi. Mol Biol Cell, 20:209–217.
30.
BrownFC, SchindelhaimCH and PfefferSR. (2011). GCC185 plays independent roles in Golgi structure maintenance and AP-1-mediated vesicle tethering. J Cell Biol, 194:779–787.
31.
LiangXH, ShenW, SunH, PrakashTP and CrookeST. (2014). TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells. Nucleic Acids Res, 42:7819–7832.
32.
ZuiderwegER, HightowerLE and GestwickiJE. (2017). The remarkable multivalency of the Hsp70 chaperones. Cell Stress Chaperones, 22:173–189.
WuH, SunH, LiangX, LimaWF and Crooke.ST (2013). Human RNase H1 is associated with protein P32 and is involved in mitochondrial pre-rRNA processing. PLoS One, 8:e71006.
35.
PobreKFR, PoetGJ and HendershotLM. (2019). The endoplasmic reticulum (ER) chaperone BiP is a master regulator of ER functions: getting by with a little help from ERdj friends. J Biol Chem, 294:2098–2108.
36.
LiangXH, ShenW, SunH, KinbergerGA, PrakashTP, NicholsJG and CrookeST. (2016). Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2′-modifications and enhances antisense activity. Nucleic Acids Res, 44:3892–3907.
37.
BennettCF, ChiangMY, ChanH, ShoemakerJE and MirabelliCK. (1992). Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol, 41:1023–1033.
38.
AdachiA, KanoF, TsuboiT, FujitaM, MaedaY and MurataM. (2010). Golgi-associated GSK3β regulates the sorting process of post-Golgi membrane trafficking. J Cell Sci, 123:3215–3225.
39.
BreusegemSY and SeamanMN. (2014). Image-based and biochemical assays to investigate endosomal protein sorting. Methods Enzymol, 534:155–178.
40.
VickersTA and CrookeST. (2014). Antisense oligonucleotides capable of promoting specific target mRNA reduction via competing RNase H1-dependent and independent mechanisms. PLoS One, 9:e108625.
41.
LiuT, DanielsCK and CaoS. (2012). Comprehensive review on the HSC70 functions, interactions with related molecules and involvement in clinical diseases and therapeutic potential. Pharmacol Ther, 136:354–374.
42.
KishorA, WhiteEJF, MatsangosAE, YanZ, TandukarB and WilsonGM. (2017). Hsp70's RNA-binding and mRNA-stabilizing activities are independent of its protein chaperone functions. J Biol Chem, 292:14122–14133.
43.
RejmanJ, BragonziA and ConeseM. (2005). Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. Mol Ther, 12:468–474.
44.
RothnieA, ClarkeAR, KuzmicP, CameronA and SmithCJ. (2011). A sequential mechanism for clathrin cage disassembly by 70-kDa heat-shock cognate protein (Hsc70) and auxilin. Proc Natl Acad Sci U S A, 108:6927–6932.
45.
TerleckySR, ChiangHL, OlsonTS and DiceJF. (1992). Protein and peptide binding and stimulation of in vitro lysosomal proteolysis by the 73-kDa heat shock cognate protein. J Biol Chem, 267:9202–9209.
46.
NakagawaT, SetouM, SeogD, OgasawaraK, DohmaeN, TakioK and HirokawaN. (2000). A novel motor, KIF13A, transports mannose-6-phosphate receptor to plasma membrane through direct interaction with AP-1 complex. Cell, 103:569–581.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
